The new location will be more than 24,000 square feet, making room for X-ray and laboratory services, which aren’t available at the current Geisinger Sunbury location. These additional services mean you can get an X-ray or blood work during a visit to ConvenientCare or during your primary care appointment.
Geisinger ConvenientCare will be open weekdays from 9 a.m. to 8 p.m. and weekends from 8 a.m. to 6 p.m. ConvenientCare clinics are the best place to go for minor health issues that can be resolved in a single visit. These include cold and flu symptoms, allergies, earaches, tick removal, sprains and minor cuts.
All primary care providers and staff from Geisinger Primary Care Sunbury will relocate from their current State Street location. The new space will also include dedicated telemedicine rooms to make it easier to see your provider or specialist without traveling to a larger medical facility.
“The relocation of our primary care office and having it in the same spot as a ConvenientCare walk-in clinic in Sunbury is a significant benefit for community members looking for health care services closer to home,” said Suzy Kobylinski, M.D., chair of Geisinger community medicine. “The addition of these services to our expanding network helps make health care easier for our neighbors in the community.”
To learn more about Geisinger ConvenientCare visit geisinger.org/urgentcare, and to learn more about Geisinger primary care visit geisinger.org/primarycare.
Geisinger is committed to making better health easier for the more than 1 million people it serves. Founded more than 100 years ago by Abigail Geisinger, the system now includes nine hospital campuses, a health plan with more than half a million members, two research centers and the Geisinger Commonwealth School of Medicine. With nearly 24,000 employees and more than 1,600 employed physicians, Geisinger boosts its hometown economies in Pennsylvania by billions of dollars annually. Learn more at www.geisinger.org, or connect with us on Facebook, Instagram, LinkedIn and Twitter.